Acute Graft Versus Host Disease - 162 Studies Found

Withdrawn : Rituximab for GVHD
:
  • Graft vs Host Disease
  • Alogenic Hematopoietic Transplant

: 2007-12-19
: Drug: Rituximab Rituximab 375 mg/m^2 is given weekly X 4.
Withdrawn : Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
: Hematologic Diseases
: 2008-06-09
: Procedure: Intrabone Marrow Injection Cord blood CB units will be thawed in a 37° CB cells will be
Completed : Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
: Graft-Versus-Host Disease
: 2005-09-12
: Drug: Infliximab A total of 6 doses of Infliximab will be
Completed : Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
:
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia

  • : 2013-09-24
    :
    • Drug: tacrolimus Tacrolimus 0.
Completed : Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    : 2006-12-06
    :
    • Drug: lithium carbonate Given

Completed : Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications
: Graft-Versus-Host Disease
: 2012-06-30
: Procedure: Bone Marrow Stromal Cell Infusion
Completed : Phase I Study of Milatuzumab for Graft Versus Host Disease
:
  • GVHD (Acute or Chronic)
  • Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)
  • : 2012-08-07
    : Drug: milatuzumab Milatuzumab is a humanized anti-CD74 antibody that is administered intravenously.
Completed : Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation
:
  • Graft-versus-host Disease
  • Relapse

: 2013-08-30
: Biological: Mesenchymal stem cells Mesenchymal stem cells infusion
Completed : Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
: Graft-vs-Host Disease
: 2002-03-15
: Drug: Visilizumab
Not yet recruiting : Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)
: Graft Vs Host Disease
: 2007-08-16
: Drug: Preimplantation factor (PIF-1) The study will includ
<<< Previous | Next >>>